338 related articles for article (PubMed ID: 16415877)
21. Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6.
Hu F; Feng AP; Liu XX; Zhang S; Xu JT; Wang X; Zhong XL; He MW; Chen HX
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):426-431. PubMed ID: 26072084
[TBL] [Abstract][Full Text] [Related]
22. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
[TBL] [Abstract][Full Text] [Related]
23. Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production.
Prescott D; McKay DM
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G487-97. PubMed ID: 21659618
[TBL] [Abstract][Full Text] [Related]
24. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.
Chiang N; Hurwitz S; Ridker PM; Serhan CN
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):e14-7. PubMed ID: 16293793
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and lipoxins.
Fierro IM
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):271-5. PubMed ID: 15982864
[TBL] [Abstract][Full Text] [Related]
26. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines.
Hu S; Mao-Ying QL; Wang J; Wang ZF; Mi WL; Wang XW; Jiang JW; Huang YL; Wu GC; Wang YQ
J Neuroinflammation; 2012 Dec; 9():278. PubMed ID: 23268791
[TBL] [Abstract][Full Text] [Related]
27. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
28. Lipoxin A4 attenuates adipose inflammation.
Börgeson E; McGillicuddy FC; Harford KA; Corrigan N; Higgins DF; Maderna P; Roche HM; Godson C
FASEB J; 2012 Oct; 26(10):4287-94. PubMed ID: 22700871
[TBL] [Abstract][Full Text] [Related]
29. Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism.
Nascimento-Silva V; Arruda MA; Barja-Fidalgo C; Fierro IM
Thromb Haemost; 2007 Jan; 97(1):88-98. PubMed ID: 17200775
[TBL] [Abstract][Full Text] [Related]
30. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
31. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
Guilford WJ; Parkinson JF
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):245-50. PubMed ID: 15985364
[TBL] [Abstract][Full Text] [Related]
32. Eicosanoids in asthma.
Wan KS; Wu WF
Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962
[TBL] [Abstract][Full Text] [Related]
33. Lipoxin A4 negatively regulates lipopolysaccharide-induced differentiation of RAW264.7 murine macrophages into dendritic-like cells.
Zhang L; Wu P; Jin SW; Yuan P; Wan JY; Zhou XY; Xiong W; Fang F; Ye DY
Chin Med J (Engl); 2007 Jun; 120(11):981-7. PubMed ID: 17624266
[TBL] [Abstract][Full Text] [Related]
34. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
[TBL] [Abstract][Full Text] [Related]
35. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
36. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
[TBL] [Abstract][Full Text] [Related]
37. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
József L; Zouki C; Petasis NA; Serhan CN; Filep JG
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
[TBL] [Abstract][Full Text] [Related]
39. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis.
Tang K; Liu J; Yang Z; Zhang B; Zhang H; Huang C; Ma J; Shen GX; Ye D; Huang B
Biochem Biophys Res Commun; 2010 Sep; 400(3):432-6. PubMed ID: 20801099
[TBL] [Abstract][Full Text] [Related]
40. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
Wada K; Qiu FH; Stahl GL; Serhan CN
J Hematother Stem Cell Res; 2001 Feb; 10(1):75-9. PubMed ID: 11276361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
